NHS

News

NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with multiple sclerosis.

Digital

With stronger foundations and a growing national appetite for change, 2026 could be the year when unified data becomes routine practice.

News

More than 20 years after its approval, NICE has backed the use of bevacizumab as a treatment for colorectal cancer for the first time.

Digital

There are six priorities that would turn the NHS into the UK’s flagship testbed for innovation.

Market Access

The ICER threshold increase is expected to allow an additional three to five medicines or indications each year to be recommended for NHS use.

Patients

Dr Ruth Chambers OBE, co-director of Raparu Consult CIC and a visiting professor at Staffordshire University, discusses her book on the NHS.